Core Viewpoint - Baolingbao achieved significant growth in Q1 2025, with a revenue of 685 million yuan, a year-on-year increase of 24.23%, and a net profit of 50.36 million yuan, up 117.35%, both reaching historical highs for the period [1] Group 1: Financial Performance - The company's comprehensive gross profit margin increased to 13.65%, up 3.67% from the same period last year [1] - The gross profit margin for the three core products (prebiotics, dietary fiber, and sugar-reducing sweeteners) reached 18.36% [1] Group 2: Product Demand and Market Strategy - There is a growing demand for sugar-reducing sweeteners, with the company's revenue from these products increasing by approximately 96% in Q1 [2] - The revenue growth for specific products includes erythritol (up 123%), allulose (up 82%), and crystalline fructose (up 80%) [2] Group 3: Project Development and Innovation - The production lines for DHA algae oil, lactulose, and HMOs have been completed and are in trial production [2] - The company has initiated the expansion project for allulose and is actively advancing the approval process for HMOs and allulose [2] - In Q1 2025, the company received three invention patent authorizations and participated in multiple industry standard formulations [2] Group 4: Market Outlook and Strategic Focus - The health food market is expected to enter a golden development period, with increasing consumer demand for functional ingredients like prebiotics and dietary fiber [2] - The company aims to leverage its technological advantages and market position to optimize product structure and innovate, adopting a "small, fine, and agile" model to meet differentiated demands [2] - Baolingbao plans to expand its domestic and international markets by utilizing its global layout and brand strength [2]

最近，一则重磅消息在网络上刷屏——国家卫生健康委员会郑重宣布,正式启动为期三年的《体重管理 年》专项行动，力促全民健康素养提升。相关数据令人警醒，我国成年居民超重率已攀升至34.3%，肥 胖率也达到了16.4%，肥胖与高血压、糖尿病、心脑血管疾病等多种慢性病紧密相连，成为威胁国民健 康的重大隐患。 当身体出现脂肪堆积，尤其是内脏脂肪含量上升时，会对健康产生潜在影响。研究表明，脂肪过度积累 可能与内分泌波动、胰岛素敏感性变化相关，进而增加2型糖尿病的患病风险；同时还可能影响心血管 健康，导致血脂水平异常、动脉健康状况改变；此外，还可能引发身体炎症反应、加重关节负担，影响 日常生活质量。因此，科学管理体重、改善身体代谢状态成为健康生活的重要课题。作为澳洲知名健康 食品品牌，Melrose麦萝氏推出绿瘦子1.0的升级产品：有机绿植精萃代谢粉2.0。这款产品将专利科技与 天然营养相结合，为消费者提供科学的体重管理参考方案，帮助人们以更健康、更科学的方式管理身体 状态，探索适合自己的健康生活路径。 专利科技，构建科学体重管理矩阵 Melrose麦萝氏绿瘦子2.0 搭载两大专利成分，构建科学体重管理矩阵。VInOgrap ...